Evidence map›Paper›PMID 36016927›Full record

ArticleFrontiers in immunology2022

Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology.

Alison McCallion, Yasmin Nasirzadeh, Harshavardhan Lingegowda, Jessica E Miller, Kasra Khalaj, SooHyun Ahn, Stephany P Monsanto, Mallikarjun Bidarimath, Danielle J Sisnett, Andrew W Craig and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Estradiol Promotes Endometriosis ProgressionCurrent pharmaceutical biotechnology · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Alison McCallionDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Yasmin NasirzadehDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Harshavardhan LingegowdaDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Jessica E MillerDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Kasra KhalajDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
SooHyun AhnDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Stephany P MonsantoDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Mallikarjun BidarimathDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Danielle J SisnettDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Andrew W CraigDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, Canada.
Steven L YoungDepartment of Obstetrics and Gynecology, Wake Forest Baptist Health, Winston-Salem, NC, United States.
Bruce A LesseyDepartment of Obstetrics and Gynecology, Wake Forest Baptist Health, Winston-Salem, NC, United States.
Madhuri KotiDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Chandrakant TayadeDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Queen's University · CAAtrium Health Wake Forest Baptist · USUniversity of North Carolina at Chapel Hill · US

Funding

SIRT1 as a Therapeutic Target in EndometriosisP01HD106485 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COX, LAURA A · 2021 to 2025
$6.8M
6 · The paper itself

Abstract

Endometriosis is an estrogen dependent, chronic inflammatory disease characterized by the growth of endometrial lining outside of the uterus. Mast cells have emerged as key players in regulating not only allergic responses but also other mechanisms such as angiogenesis, fibrosis, and pain. The influence of estrogen on mast cell function has also been recognized as a potential factor driving disease pathophysiology in number of allergic and chronic inflammatory conditions. However, precise information is lacking on the cross talk between endocrine and immune factors within the endometriotic lesions and whether that contributes to the involvement of mast cells with disease pathophysiology. In this study, we observed a significant increase in mast cell numbers within endometriotic lesions compared to matched eutopic endometrium from the same patients. Compared to eutopic endometrium, endometriotic lesions had significantly higher levels of stem cell factor (SCF), a potent growth factor critical for mast cell expansion, differentiation, and survival for tissue resident mast cells. Targeted mRNA Q-PCR array revealed that the endometriotic lesions harbour microenvironment (upregulation of CPA3, VCAM1, CCL2, CMA1, CCR1, and KITLG) that is conducive to mast cells recruitment and subsequent differentiation. To examine cross-talk of mast cells within the endometriotic lesion microenvironment, endometriotic epithelial cells (12Z) and endometrial stromal cells (hESC) incubated with mast cell-conditioned media showed significantly increased production of pro-inflammatory and chemokinetic cytokines. To further understand the impact of estrogen on mast cells in endometriosis, we induced endometriosis in C57BL/6 mice. Mature mast cells were significantly higher in peritoneal fluid of estrogen-treated mice compared to untreated mice within the sham operated groups. Mouse endometriotic lesion tissue revealed several genes (qRT-PCR) relevant in mast cell biology significantly upregulated in the estrogen treated, endometriosis-induced group compared to control endometrium. The endometriotic lesions from estrogen treated mice also had significantly higher density of Alcian blue stained mast cells compared to untreated lesions or control endometrium. Collectively, these findings suggest that endometriotic lesions provide a microenvironment necessary for recruitment and differentiation of mast cells. In turn, mast cells potentially release pro-inflammatory mediators that contribute to chronic pelvic pain and endometriosis disease progression.

Indexed as

EndometriosisAnimalsCell CountEstrogensFemaleHumansMast CellsMiceMice, Inbred C57BLEstrogensendometriosisestrogenic inflammationimmune crosstalkimmune microenvironmentmast cell recruitment and maturationstem cell factor

Identifiers

PMID36016927
PMCPMC9396281
OpenAlexW4290744503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.